Covered recipient · General Payments record
PENNY R CAIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$3,038.92
- Reported across 33 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $903.32 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $202.48 | 2 |
| Amgen Inc. | $157.86 | 2 |
| Acerta Pharma LLC | $121.90 | 1 |
| Abbott Laboratories | $120.93 | 1 |
| Astellas Pharma US Inc | $119.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $98.48 | 1 |
| Stryker Corporation | $81.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $120.93 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240966691 | CMS |
| Amgen Inc. | $80.27 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229358282 | CMS |
| Amgen Inc. | $77.59 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229358278 | CMS |
| Astellas Pharma US Inc | $119.85 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238618890 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.90 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206199492 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $98.48 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225483664 | CMS |
| Novo Nordisk Inc | $99.56 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189148404 | CMS |
| Novo Nordisk Inc | $102.92 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188636476 | CMS |
| Stryker Corporation | $81.82 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228057016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.